Alan Herschtal

Alan Herschtal is a Senior Biostatistician and Research Fellow at Monash University's Clinical Trials Centre. He specializes in clinical trials methodology across Oncology and Cardiovascular disease. His key responsibilities include statistical design, analysis, reporting, and grant preparation. He holds leadership roles in two active research projects: 'Co-design and evaluation of a resource to improve patient-clinician communication in rural chronic disease settings' (2024–2027) and 'Flexible Modelling of Count Outcomes in Clinical Trials' (2024).

His research focuses on Flexible parametric survival modelling and Modelling of zero-inflated data, with notable contributions to imaging advancements in prostate cancer (PSMA PET-CT) and lung cancer therapies (SABR vs. standard radiotherapy). His work aligns with UN Sustainable Development Goals related to health equity and innovation.

Recent articles highlight advancements in trial design for eating disorders, pulmonary function post-radiotherapy, and cardiovascular risk screening. Projects emphasize improving rural healthcare communication and statistical methodologies for count data in clinical research.

He collaborates internationally and leads grant applications, with a focus on translational research linking statistical innovation to clinical outcomes. His expertise bridges biostatistics, clinical oncology, and public health initiatives.